Feng Y, He L
Curr Med Sci. 2024; 44(4):669-679.
PMID: 39096477
DOI: 10.1007/s11596-024-2907-x.
Shaw L, Patel K, Lala-Trindade A, Feltovich H, Vieira L, Kontorovich A
JACC Adv. 2024; 3(6):100980.
PMID: 38938863
PMC: 11198310.
DOI: 10.1016/j.jacadv.2024.100980.
Gallo G, Savoia C
Int J Mol Sci. 2024; 25(12).
PMID: 38928371
PMC: 11203528.
DOI: 10.3390/ijms25126661.
Shah A, Sabharwal N, Day J
BJA Educ. 2024; 24(5):155-163.
PMID: 38646450
PMC: 11026937.
DOI: 10.1016/j.bjae.2024.02.003.
Hegner P, Wester M, Tafelmeier M, Provaznik Z, Klatt S, Schmid C
Eur Respir J. 2024; 63(6).
PMID: 38636989
PMC: 11154749.
DOI: 10.1183/13993003.00579-2024.
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.
Hiraiwa H, Okumura T, Murohara T
Am J Cardiovasc Drugs. 2024; 24(3):343-369.
PMID: 38575813
PMC: 11093799.
DOI: 10.1007/s40256-024-00641-9.
Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach.
Stoicescu L, Crisan D, Morgovan C, Avram L, Ghibu S
Int J Mol Sci. 2024; 25(2).
PMID: 38255869
PMC: 10815792.
DOI: 10.3390/ijms25020794.
Assessment of the cardiac output at rest and during exercise stress using real-time cardiovascular magnetic resonance imaging in HFpEF-patients.
Schulz A, Mittelmeier H, Wagenhofer L, Backhaus S, Lange T, Evertz R
Int J Cardiovasc Imaging. 2024; 40(4):853-862.
PMID: 38236362
PMC: 11052864.
DOI: 10.1007/s10554-024-03054-6.
Insights into the Interaction of Heart Failure with Preserved Ejection Fraction and Sleep-Disordered Breathing.
Wester M, Arzt M, Sinha F, Maier L, Lebek S
Biomedicines. 2023; 11(11).
PMID: 38002038
PMC: 10669157.
DOI: 10.3390/biomedicines11113038.
Large animal models to study effectiveness of therapy devices in the treatment of heart failure with preserved ejection fraction (HFpEF).
Fisher S, Murally A, Rajabally Z, Almas T, Azhar M, Cheema F
Heart Fail Rev. 2023; 29(1):257-276.
PMID: 37999821
DOI: 10.1007/s10741-023-10371-w.
A Narrative Review on the Efficacy and Safety of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction.
Pius R, Odukudu G, Olorundare I, Makanjuola D, Komolafe R, Njoku C
Cureus. 2023; 15(9):e45794.
PMID: 37872937
PMC: 10590658.
DOI: 10.7759/cureus.45794.
Pediatric heart failure with preserved ejection fraction, a review.
Quennelle S, Bonnet D
Front Pediatr. 2023; 11:1137853.
PMID: 37601131
PMC: 10433757.
DOI: 10.3389/fped.2023.1137853.
A network medicine approach to study comorbidities in heart failure with preserved ejection fraction.
Lanzer J, Valdeolivas A, Pepin M, Hund H, Backs J, Frey N
BMC Med. 2023; 21(1):267.
PMID: 37488529
PMC: 10367269.
DOI: 10.1186/s12916-023-02922-7.
The double-hit protocol induces HFpEF and impairs myocardial ubiquitin-proteasome system performance in FVB/N mice.
Lira J, Guymon A, Yang L, Sternburg J, Giri S, Wang X
Front Physiol. 2023; 14:1208153.
PMID: 37362441
PMC: 10285383.
DOI: 10.3389/fphys.2023.1208153.
Hypertensive response to exercise, hypertension and heart failure with preserved ejection fraction (HFpEF)-a continuum of disease?.
Wiech P, Wurzburger L, Rossi V, Caselli S, Schmied C, Niederseer D
Wien Klin Wochenschr. 2023; 135(23-24):685-695.
PMID: 37069407
PMC: 10713678.
DOI: 10.1007/s00508-023-02195-3.
Thyroid Hormone and Heart Failure: Charting Known Pathways for Cardiac Repair/Regeneration.
Mantzouratou P, Malaxianaki E, Cerullo D, Lavecchia A, Pantos C, Xinaris C
Biomedicines. 2023; 11(3).
PMID: 36979954
PMC: 10046827.
DOI: 10.3390/biomedicines11030975.
Efficacy of Ranolazine to Improve Diastolic Performance in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis.
Cempaka Putri D, Andrianto A, Al-Farabi M, Saputra P, Nugraha R
Eur Cardiol. 2023; 18:e02.
PMID: 36844933
PMC: 9947928.
DOI: 10.15420/ecr.2022.10.
Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis.
Treewaree S, Kulthamrongsri N, Owattanapanich W, Krittayaphong R
Front Cardiovasc Med. 2023; 10:1046194.
PMID: 36824458
PMC: 9941559.
DOI: 10.3389/fcvm.2023.1046194.
Coronary Microvascular Dysfunction in Patients with Congenital Heart Disease.
Vanreusel I, Segers V, Van Craenenbroeck E, Van Berendoncks A
Curr Cardiol Rev. 2023; 19(4):e190123212886.
PMID: 36658708
PMC: 10494268.
DOI: 10.2174/1573403X19666230119112634.
Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes.
Mone P, Lombardi A, Kansakar U, Varzideh F, Jankauskas S, Pansini A
J Pharmacol Exp Ther. 2022; 384(1):116-122.
PMID: 36549862
PMC: 9827502.
DOI: 10.1124/jpet.121.001251.